PRESS: Celadon Pharmaceuticals highlighted in directors talk interview on Investing and Spring Budget Insights by Gervais Williams
We are pleased to share with you some exciting news about our recent feature on DirectorsTalk, where Gervais Williams provides insights into the impact of the Spring budget on investing and highlights several companies, including Celadon Pharmaceuticals Plc.
Gervais offers a comprehensive analysis of the budget’s implications for the UK equity markets and investors, highlighting noteworthy aspects that stood out to him. We are thrilled to have been recognised as a company to watch.
OTHER POSTS
-
PRESS: Britain could be getting high on the benefits of a full-scale medical cannabis industry
-
PRESS: British Pain Society features Celadon Pharmaceuticals Plc
-
PRESS: Celadon Pharmaceutical’s CEO Jim Short featured discussing new MHRA framework
-
PRESS: Inside huge top-secret legal cannabis facility hidden away in Birmingham that is the size of three football pitches